Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionitrile SCHEMBL27536393 | 0.80 | MAOA (0.44) | MAOAMAOBSMN1; SMN2CYP2C19CYP1A2 | |
| SCHEMBL10396645 | 0.80 | CYP1A2 (0.52) | MAOAMAOBSMN1; SMN2CYP2C19CYP1A2 | |
| Water SCHEMBL28337531 | 0.80 | CYP2C19 (0.54) | MAOAMAOBSMN1; SMN2CYP2C19CTSB | |
| Water SCHEMBL27972561 | 0.80 | CYP2C19 (0.54) | MAOAMAOBSMN1; SMN2CYP2C19CTSB | |
| SCHEMBL8845028 | 0.78 | ALDH1A1 (0.50) | MAOAMAOBSMN1; SMN2CYP2C19CYP1A2 | |
| SCHEMBL13888921 | 0.78 | BCHE (0.42) | IDO1ALDH1A1HTTHPGD | |
| SCHEMBL18239237 | 0.77 | CYP2C19 (0.44) | MAOAMAOBSMN1; SMN2CYP2C19CYP1A2 | |
| SCHEMBL5385519 | 0.77 | CYP2C19 (0.48) | MAOAMAOBSMN1; SMN2CYP2C19CTSB | |
| Cyanate SCHEMBL28254557 | 0.77 | CYP2C19 (0.48) | MAOAMAOBSMN1; SMN2CYP2C19CYP1A2 | |
| SCHEMBL206 | 0.77 | CYP2C19 (0.56) | MAOBSMN1; SMN2CYP2C19CTSBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-14 | — | — | US | disclosed |
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-14 | — | — | US | disclosed |
| US-20190105646-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-04-11 | — | — | US | disclosed |
| WO-2017164813-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2017-09-28 | — | — | WO | disclosed |
| EP-1230230-B1 | INDENO-DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | AVENTIS PHARMA GMBH (DE) | 2003-09-17 | — | — | EP | disclosed |
| EP-0724435-B1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | SEARLE & CO (US) | 2002-08-14 | — | — | EP | disclosed |
| EP-1230230-A1 | INDENO-, NAPHTHO-, AND BENZOCYCLOHEPTA-DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | Aventis Pharma Deutschland GmbH (DE) | 2002-08-14 | — | — | EP | disclosed |
| US-6387935-B1 | ANOREXIGENIC AGENT | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-05-14 | — | — | US | disclosed |
| WO-2001032638-A1 | INDENO-, NAPHTHO-, AND BENZOCYCLOHEPTA-DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-05-10 | — | — | WO | disclosed |
| US-5821267-A | MODULATING THE INDUCIBLE ISOFORM OVER THE CONSTITUTIVE; HYPERTENSIVE, ANTIARTHRITIC AND DIABETIC AGENTS; THERAPY WITH CYTOKINES; TOXIC AND SEPTIC SHOCK | G.D. SEARLE & CO. (US) | 1998-10-13 | — | — | US | disclosed |
| EP-0707577-A1 | HEME BINDING COMPOUNDS AND USE THEREOF | MEDICAL COLLEGE OF WISCONSIN RESEARCH FOUNDATION, INC. (US) | 1996-04-24 | — | — | EP | disclosed |
| US-5464858-A | Heme binding compounds and use thereof | THE MEDICAL COLLEGE OF WISCONSIN RESEARCH FOUNDATION, INC. (US) | 1995-11-07 | — | — | US | disclosed |
| US-5424447-A | Heme binding compounds and use thereof | THE MEDICAL COLLEGE OF WISCONSIN RESEARCH FOUNDATION, INC. (US) | 1995-06-13 | — | — | US | disclosed |
| WO-1995011014-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1995-04-27 | — | — | WO | disclosed |
| WO-1995001972-A1 | HEME BINDING COMPOUNDS AND USE THEREOF | THE MEDICAL COLLEGE OF WISCONSIN RESEARCH FOUNDATION, INC. (US) | 1995-01-19 | — | — | WO | disclosed |
| EP-0186426-B1 | TETRAZOLYL COMPOUNDS AND THEIR PHARMACEUTICAL USE | Lilly Industries Limited (GB) | 1990-09-12 | — | — | EP | disclosed |
| US-4898874-A | Acetic acid derivatives of 3-aryl-2,1-benzisoxazole and esters and amides thereof | A. H. ROBINS COMPANY, INC. (US) | 1990-02-06 | — | — | US | disclosed |
| EP-0260924-A1 | Antiinflammatory derivatives of 3-aryl-2,1-benzisoxazole | A.H. ROBINS COMPANY, INCORPORATED (US) | 1988-03-23 | — | — | EP | disclosed |
| EP-0186426-A2 | Tetrazolyl compounds and their pharmaceutical use | Lilly Industries Limited (GB) | 1986-07-02 | — | — | EP | disclosed |
| US-3988375-A | HERBICIDES | MONSANTO COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | PRDX3, PRDX4, PRDX2 | MAOA 1109/4885MAOB 476/4885SMN1; SMN2 4353/4885 |
| US-20190105646-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | PRDX3, PRDX4, PRDX6 | MAOA 827/4885MAOB 305/4885SMN1; SMN2 4370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.